Rhythm Pharmaceuticals buy Wells Fargo & Company
Start price
08.11.23
/
50%
€26.00
Target price
08.11.24
€37.40
Performance (%)
72.31%
Price
26.08.24
€44.80
Summary
This prediction is currently active. With a performance of 72.31% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 08.11.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rhythm Pharmaceuticals | 9.268% | 9.268% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Wells Fargo & Company from $38.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€48.34
19.12.24
19.12.24
5.66%
26.08.24
26.08.24